Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management - ACUITY: 1-Year Results


The goal of this study was to report long-term follow-up from the use of one of three antithrombotic regimens in the management of acute coronary syndromes (ACS): 1) heparin and a glycoprotein (GP) IIb/IIIa inhibitor, 2) bivalirudin and a GP IIb/IIIa inhibitor, or 3) bivalirudin alone.